The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

21 Jun 2012 07:00

RNS Number : 8246F
Port Erin Biopharma Investments Ltd
21 June 2012
 



Port Erin Biopharma Investments Limited

 

 ("Port Erin" or the "Company")

 

Director's Dealing

 

 

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 250,000 Ordinary Shares at a price of 7 pence per share on 20 June 2012,

 

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a Director of Galloway Limited.

 

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 4,191,000, representing 12.7% of the issued ordinary share capital of the Company.

 

 

Enquiries:

 

 

Port Erin Biopharma Investments Limited

 

Denham Eke

(+44) 1624 639396

 

 

Libertas Capital Corporate Finance Limited

 

Sandy Jamieson

(+44) 20 7569 9650

 

 

Rivington Street Corporate Finance Limited

 

John Levinson

(+44) 20 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQBLFLLQFEBBQ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.